Optometrist · Brooklyn, NY
NPI
1932548708
Since 2013
Specialty
Optometrist
Code 152W00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
187 Avenue U
Brooklyn, NY, 11223
Phone (718) 373-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
640 services
Medicare patients, 2024
84
Average age 74
Drug cost, 2024
$946K
2,008 prescriptions
Company payments, 2025
$1,275
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalya Rooney was code 68761 (eye), 101 times for 30 patients. In total Natalya Rooney billed 640 services in 19 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 68761 Eye | Office | 101 | 30 | $98.45 | $9,943 |
| 76512 Ultrasound - Nonspecific | Office | 93 | 43 | $39.68 | $3,690 |
| 92285 Standard X-ray | Office | 83 | 72 | $18.87 | $1,566 |
| 92012 Ophthalmological E&M | Office | 75 | 36 | $76.07 | $5,705 |
| 92250 Angiography | Office | 75 | 70 | $30.30 | $2,272 |
| 92083 Vision, Hearing, and Speech Services | Office | 71 | 65 | $57.50 | $4,082 |
| 92004 Ophthalmological E&M | Office | 44 | 44 | $133.21 | $5,861 |
| 92014 Ophthalmological E&M | Office | 29 | 28 | $103.96 | $3,015 |
| 92286 Standard X-ray | Office | 19 | 19 | $31.03 | $590 |
By year: 2022 $254K for 5,137 services; 2023 $94K for 2,008 services; 2024 $44K for 640 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalya Rooney prescribed most often to Medicare patients was Restasis (Cyclosporine), with 671 prescriptions and refills. In total Natalya Rooney wrote 2,008 Medicare prescriptions that cost $946K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 671 | 713 | 150 | $435K |
| Xiidra Lifitegrast | 399 | 429 | 84 | $276K |
| Azelastine Hcl Generic | 150 | 162 | 36 | $1,514 |
| Latanoprost Generic | 118 | 148 | 33 | $700 |
| Cyclosporine Generic | 98 | 110 | 27 | $27K |
| Lumigan Bimatoprost | 81 | 102 | 22 | $25K |
| Zerviate Cetirizine Hcl | 80 | 82 | 15 | $22K |
| Cequa Cyclosporine | 72 | 78 | 22 | $43K |
| Restasis Multidose Cyclosporine | 29 | 29 | Under 11 | $18K |
| Timolol Maleate Generic | 28 | 56 | Under 11 | $190 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 28 | 51 | Under 11 | $319 |
| Tyrvaya Varenicline Tartrate | 24 | 24 | Under 11 | $15K |
| Combigan Brimonidine Tartrate/Timolol | 23 | 44 | Under 11 | $7,978 |
| Alphagan P Brimonidine Tartrate | 21 | 34 | Under 11 | $5,435 |
| Miebo Perfluorohexyloctane/Pf | 19 | 25 | Under 11 | $22K |
Brand drugs: 1,616 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalya Rooney $1,275 ($1,275 in general payments such as food, travel and fees) from 10 companies. The largest payer was Bausch & Lomb Americas Inc. with $462.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 10 | $462 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $188 |
| Harrow Eye, LLC | 4 | $161 |
| LKC Technologies, Inc. | 1 | $139 |
| Dompe US, Inc. | 1 | $122 |
| CooperVision Inc. COO | 1 | $89.66 |
| Alcon Vision LLC ALC | 2 | $61.59 |
| Biotissue Holdings Inc. | 1 | $20.34 |
| Johnson & Johnson Vision Care, Inc. JNJ | 1 | $17.04 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $14.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.